Accelerate to discover

Webinar recording: Metabolic MR Imaging of Obesity

Mar 24, 2020

In this webinar recording. Dr. Ruslan Hlushchuk (Universität Bern, Institute of Anatomy) and Dr. Kjell Laperre (Bruker Biospin’s Pre-Clinical Imaging Division) will introduce a new radiopaque contrast agent called μAngiofil that can be used to overcome this challenge. For ex vivo angiography, it provides microvascular imaging down to the fine-capillary level, without requiring prior tissue maceration or bone removal/decalcification. Other advantages are that the sample can be used for subsequent correlative morphology and quantitative analysis can be performed, without requiring extensive post-processing.

Do you want to learn more? Watch the recorded webinar!

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 255 700 886

Send Message

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey